Weight changes following antidiabetic mediation use: Real-world evidence from health system data.
Beini LyuMorgan E GramsLesley A InkerAlexander R ChangElizabeth SelvinJung-Im ShinPublished in: Obesity science & practice (2022)
In real-world practice, SGLT2i and GLP1RA were associated with significant weight loss compared with sulfonylureas and DPP4i. These results may further motivate uptake of SGLT2i and GLP1RA, especially among patients who were overweight or had obesity.
Keyphrases
- weight loss
- bariatric surgery
- rheumatoid arthritis
- roux en y gastric bypass
- gastric bypass
- weight gain
- disease activity
- primary care
- healthcare
- ankylosing spondylitis
- electronic health record
- glycemic control
- obese patients
- big data
- social support
- interstitial lung disease
- type diabetes
- physical activity
- quality improvement
- adipose tissue
- deep learning
- skeletal muscle
- high fat diet induced